Inogen’s share price has performed poorly since I rated the stock a Buy in July 2023, and for good reason. Another round of senior executive changes combined with a questionable acquisition has ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid fourth-quarter 2024 ...

Tudor Investment Corp ET AL lifted its position in Inogen, Inc. (NASDAQ:INGN – Free Report) by 44.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and ...

Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” first quarter 2025 investor letter. A copy of the letter can be downloaded ...

Inogen (INGN) came out with a quarterly loss of $0.2 per share versus the Zacks Consensus Estimate of a loss of $0.22. This compares to a loss of $0.25 per share a year ago. These figures are adjusted ...

Welcome to Inogen's Second Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded today, August 7, 2025. I would now like to turn the call over ...

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of Directors has authorized a share ...

BEVERLY, Mass. (AP) — BEVERLY, Mass. (AP) — Inogen Inc. (INGN) on Tuesday reported a loss of $7.1 million in its fourth quarter. The Beverly, Massachusetts-based company said it had a loss of 26 cents ...